ESR1 and neoplasm: Thus, the value of proteasome ChTL activity in the tumor influenced the percent of ER (β = 0.46; p = 0.000), PR (β = 0.31; p = 0.000) and the Ki-67 (β = 0.25; p = 0.000) expressing cells.